<DOC>
	<DOC>NCT02082236</DOC>
	<brief_summary>The purpose of this study is to establish the single and multiple-dose pharmacokinetics (PK) of sublingual administration of the Sufentanil Sublingual Microtablet (SSM) 30 mcg and compare the pharmacokinetics of a single dose of SSM 30 mcg to 2 doses of SSM 15 mcg administered 20 minutes apart.</brief_summary>
	<brief_title>Pharmacokinetics of Sufentanil Sublingual Microtablet 30 mcg and 15 mcg in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Sufentanil</mesh_term>
	<criteria>1. Nonsmoking male or female subjects 2. Aged between 18 and 45 years inclusive 3. Subjects must have Body Mass Index (BMI) between 18 and 30, inclusively. 1. Subjects who are taking overthecounter medication (except for single dose multivitamin supplements or acetaminophen of less than 2 g/day) within 14 days prior to start of sufentanil dosing prescription medications or over the counter (OTC) medications 2. Female subjects who are pregnant 3. Subjects with chronic obstructive pulmonary disease, sleep apnea, or other significant respiratory disorders</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Plasma concentrations</keyword>
</DOC>